Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights
  • Choose License Type

India medical nutrition market, by Nutrition Type (Proteins, Carbohydrates, Multi-vitamins and Antioxidants, Amino Acid, Fibers, Minerals, and Others), by Patient Type (Infant Nutrition, Adult Nutrition, and Geriatric Nutrition), by Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, and Others), by Route of Administration (Oral, Enteral, and Parenteral), by Distribution Channel (Hospitals, Home Care Settings, Long Term Care, and Ambulatory Surgical Centers), and by Region (North India, South India, East India, West India, Central India, and North East India), is estimated to be valued at US$ 404.1 Million in 2021 and is expected to exhibit a CAGR of 8.6% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.

The increasing prevalence of chronic diseases such as diabetes, chronic kidney disease and others are resulting in an increased risk of malnutrition, which is expected to drive the India medical nutrition market growth. According to report published by Department of Nephrology, Opal Hospital, Uttar Pradesh, India, in 2019, the prevalence of chronic kidney disease ranged from 8% to 17% amongst the total population.

India medical nutrition market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic has negatively affected various industries globally. Supply chain and manufacturing activities in India have been disrupted due to nationwide lockdown in the past few months; while states such as Maharashtra, Gujarat, Rajasthan, and others are facing problems with regards to transportation of medical devices due to partial lockdowns and termination of interstate transport in India. During the COVID-19 pandemic, the demand for nutrition supplements increased as these nutritional products are considered to aid in the maintenance of a healthy diet and improve immunity in individuals. Therefore various India-based companies are launching nutritional products for boosting the immunity of the individuals, which is expected to drive demand of the medical nutritional products in the market. For instance, in February 2021, Lupin Limited, a pharmaceutical company, announced the launch of the Be-one nutritional product in India during the COVID-19 pandemic, it contains Ashwagandha, Shatavari, and Shilajit that boost the energy levels and improve immunity of individuals.

Browse 53 Market Data Tables and 49 Figures spread through 232 Pages and in-depth TOC on “India Medical Nutrition Market”- Forecast to 2028, India medical nutrition market, by Nutrition Type (Proteins, Carbohydrates, Multi-vitamins and Antioxidants, Amino Acid, Fibers, Minerals, and Others), by Patient Type (Infant Nutrition, Adult Nutrition, and Geriatric Nutrition), by Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, and Others), by Route of Administration (Oral, Enteral, and Parenteral), by Distribution Channel (Hospitals, Home Care Settings, Long Term Care, and Ambulatory Surgical Centers), and by Region (North India, South India, East India, West India, Central India, and North East India)

To know the latest trends and insights prevalent in the India Medical Nutrition Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/india-medical-nutrition-market-4511

The increasing number of product launches is expected to drive the growth of the India medical nutrition market over the forecast period. For instance, in November 2019, Dr Reddy's Laboratories launched a diabetes nutrition drink called 'Celevida‘. Celevida contains high protein, high fiber, and slowly digestable carbohydrates, which helps in managing the postprandial blood glucose response and satiety.

Key Takeaways of the India medical nutrition market:

  • The India medical nutrition market is expected to exhibit a CAGR of 8.6% during the forecast period. Key players are entering the market through strategic partnerships with regional, local governments, and non-government organizations. For instance, in September 2019, Abbott Laboratories collaborated with Nutrition Society of India to release the first India-specific dietary recommendations for patients suffering from GI (gastrointestinal) conditions, ranging from functional constipation and peptic ulcers to obesity, chronic pancreatitis, and irritable bowel syndrome. These recommendations can be customized according to the individual’s ideal target body weight, nutritional requirements, preferred cooking methods, and other relevant factors.
  • Among Nutrition types, Proteins segment is expected to drive the segment growth in the India medical nutrition market, owing to the launch of novel protein products. For instance, in June 2021, Naturell India, a nutritional company in India, announced the launch of Max Protein (peanut butter), which provides protein, fiber, and helps to provide strength and vigor in individuals.
  • Major players operating in the India medical nutrition market are Abbott Laboratories, Baxter International Inc., Danone S.A., Nestlé S.A., GlaxoSmithKline plc., Sun Pharmaceutical Industries Ltd., Fresenius Kabi AG, BASF, Zeon Lifesciences Ltd., Mead Johnson & Company, LLC., B. Braun Melsungen AG., Nutrimed Healthcare Pvt. Ltd, and Zenova Bio Nutrition.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.